James Altland was appointed as interim Chief Financial Officer at CorMedix effective October 2015. Previously, Mr. Altland served as Senior Vice President of Finance and Corporate Development of Onconova Therapeutics, Inc., a pharmaceutical company focused on discovering and developing novel small molecule drug candidates to treat cancer, from February 2007 to May 2014. Before joining Onconova, Mr. Altland was a Partner with Tatum, a leading professional and interim services firm headquartered in New York, New York. Mr. Altland received his B.S. in Accounting in 1971 from the University of Akron.